Understanding Perimenopause
What is perimenopause?
Perimenopause is the hormonal transition that typically begins sometime between ages 35 and 48 and ends at menopause, defined as 12 consecutive months without a period. For most women it lasts 4 to 8 years, but symptoms often begin long before cycles become obviously irregular. If you are in your late 30s, 40s, or early 50s and something feels different, your instinct is probably correct.
Perimenopause is one of the most underdiagnosed conditions in women's health. The hormonal picture is genuinely messy: estradiol does not fall in a smooth line; it rises and crashes unpredictably while progesterone declines earlier and more consistently. A single lab draw often looks normal. Women are frequently told they are too young, that their labs look fine, or that their symptoms are simply stress or aging. Too often, an SSRI is prescribed without anyone asking about cycles, sleep, or vasomotor symptoms.
At Midwest Mind & Body Healthcare, perimenopause care is built on a different premise. Kim Wohlwend, MSN, APRN, is dual ANCC board-certified as both a Family Nurse Practitioner and a Psychiatric-Mental Health Nurse Practitioner. That matters in perimenopause specifically, because mood changes, sleep disruption, anxiety, and brain fog are hormonal symptoms as much as they are psychiatric ones. Treating them well requires someone who can hold both lenses at once, order a thoughtful lab panel, actually read the results, and decide whether the right next step is hormone therapy, a non-hormonal medication, a lifestyle adjustment, or some combination.
Every initial visit is a full hour. Follow-ups are focused and unhurried. Labs are drawn at a local lab convenient to you. Prescriptions go to the pharmacy you already use. You have direct access to your clinician between visits through the patient portal.
Kimberly Wohlwend, MSN, APRN
Family Nurse Practitioner, Board-Certified · Psychiatric-Mental Health Nurse Practitioner, Board-Certified
Kim founded Midwest Mind & Body Healthcare in Papillion, Nebraska to bring integrated hormone and mental-health care to women across the Omaha metro and 16 states by telehealth. Dual ANCC board certification lets her address mood, sleep, and hormone changes in the same visit instead of bouncing patients between specialists. Meet the team →
Common Symptoms
What perimenopause can look like.
Most women have some combination of the following. You do not need every symptom to be in perimenopause, and you do not need a formal diagnosis to book a visit. If your body has changed and your old explanations no longer fit, that is reason enough.
Irregular cycles
Cycle length shifting by 7 or more days, heavier or lighter bleeding, skipped periods, or more intense PMS. Often the first measurable sign of perimenopause, typically appearing in the early 40s but sometimes sooner.
Hot flashes & night sweats
Sudden waves of heat with flushing and sweating, most often at night. Vasomotor symptoms are a core feature of perimenopause and frequently continue for 7 to 10 years if untreated. Hormone therapy is the most effective treatment.
Sleep disruption
Trouble falling asleep, waking at 3 a.m. unable to return to sleep, and unrefreshing sleep. Partly driven by night sweats, partly by independent effects of falling progesterone on sleep architecture.
Mood changes
New or worsening anxiety, irritability, low mood, or panic symptoms. Perimenopause roughly doubles the risk of a depressive episode, especially in women with prior mood history or PMDD. See our perimenopausal and postpartum mood page.
Brain fog
Word-finding difficulty, loss of short-term recall, slower processing speed. Frightening, exhausting, and usually reversible. Estrogen supports prefrontal cognition, and symptoms often improve when estradiol levels stabilize.
Vaginal dryness & GSM
Genitourinary syndrome of menopause: vaginal dryness, burning, painful intercourse, recurrent UTIs, and urinary urgency. Unlike hot flashes, GSM does not resolve on its own and typically worsens over time without treatment.
Low libido & fatigue
Loss of sexual interest, reduced sensation and arousal, and a deep fatigue that sleep does not fix. Multi-factorial: estrogen, testosterone, sleep, relationship context, and thyroid all contribute.
Weight redistribution
Shift of fat from hips and thighs toward the abdomen, often without a large change in total weight. Driven by estrogen decline, insulin resistance, and muscle loss. We address this alongside medical weight-loss strategies when indicated.
Our Approach
How perimenopause care works here.
Comprehensive evaluation
60-minute first visit covering cycle and symptom history, personal and family medical history, current medications, contraception, mood, sleep, and sexual health. Labs typically include FSH, estradiol, TSH, free T4, DHEA-S, CBC, CMP, lipids, fasting glucose, HbA1c, vitamin D, vitamin B12, and ferritin, drawn at a lab convenient to you.
Individualized plan
A written plan tailored to your history, contraindications, and goals. Options may include estradiol (oral, transdermal patch, or topical gel), progesterone, local vaginal estrogen, non-hormonal alternatives for vasomotor symptoms, and targeted lifestyle interventions. We choose route, dose, and agent deliberately, not by default.
Close follow-up
First follow-up 6 to 8 weeks after starting therapy, then roughly every 3 to 6 months, with repeat labs and symptom review. Doses are adjusted based on symptom response and tolerability. You have direct messaging access to your clinician through the patient portal between visits.
Treatment Options
Hormonal and non-hormonal options.
Hormone therapy is effective, generally well tolerated, and recommended by major professional societies, including the Menopause Society, for healthy women under 60 or within 10 years of menopause who have bothersome symptoms. It is not right for everyone, and it is not the only option. The following is a plain-language overview of what we consider and discuss. Any specific prescription requires a clinician evaluation.
Estradiol (systemic estrogen):
- Transdermal patch. Typically our default route. The patch bypasses the liver, which is associated with a lower risk of blood clots than oral estrogen and usually smoother symptom control.
- Topical gel or spray. Useful for women who do not tolerate patch adhesives or who want more granular dose adjustment.
- Oral estradiol. Effective and low-cost; reasonable for women without clot-risk factors who prefer a pill.
- Vaginal estrogen (cream, tablet, or ring). A separate decision from systemic HRT. Treats vaginal dryness, painful intercourse, and recurrent UTIs with very low systemic absorption, and is safe for many women who cannot use systemic estrogen.
Progesterone: Women with a uterus who take systemic estrogen need a progestogen to protect the endometrium from unopposed-estrogen-related cancer risk.
- Micronized progesterone (Prometrium). Our preferred option. Bioidentical, oral, taken at bedtime. Independently supportive of sleep for many women.
- Levonorgestrel IUD (Mirena). Provides endometrial protection plus contraception, both of which are often still needed in early perimenopause. A good choice for women with heavy bleeding.
Testosterone for women: Low-dose testosterone can improve libido, energy, and sometimes mood and body composition in selected women with documented low levels and persistent symptoms despite adequate estrogen. In the United States, testosterone for women is off-label: there is no FDA-approved female formulation, so we use compounded preparations at physiologic doses. Because of this, we currently offer testosterone therapy for women to Nebraska patients only. See our testosterone therapy for women page.
Non-hormonal options: For women with contraindications to estrogen, women who prefer not to use hormones, or women with residual symptoms on HRT.
- SSRIs and SNRIs. Low-dose paroxetine, escitalopram, venlafaxine, and desvenlafaxine reduce hot flash frequency and severity. Paroxetine 7.5 mg (Brisdelle) is FDA-approved specifically for vasomotor symptoms.
- Gabapentin. Particularly useful for night sweats and sleep-disrupting hot flashes.
- Fezolinetant (Veozah). An NK3 receptor antagonist that directly targets the hypothalamic hot-flash pathway, non-hormonal.
- Oxybutynin. Older option, helpful for vasomotor symptoms in some women.
- Lifestyle and behavioral. Strength training 2 to 3 times per week, protein at each meal, alcohol moderation, cognitive-behavioral therapy for insomnia (CBT-I), and cooling strategies all have measurable effect sizes and are part of most plans.
What Makes Us Different
Three things we do differently in perimenopause care.
Integrated mood & hormones
A dual ANCC board-certified psychiatric and family NP can address anxiety, depression, and hormone change in the same visit, rather than bouncing you between specialists.
Labs actually reviewed
Results are read in context, compared to prior values, and explained to you in plain language, not dismissed as "normal."
Individualized, not protocolized
We do not apply the same regimen to every patient. Route, dose, and progestogen choice are selected for you.
Who HRT is not for. Absolute or relative contraindications include a history of estrogen-sensitive cancers (breast, endometrial), active or recent venous thromboembolism or stroke, undiagnosed vaginal bleeding, and severe active liver disease. A history of migraine with aura, uncontrolled hypertension, high cardiovascular risk, or gallbladder disease requires individualized discussion and often favors the transdermal route. All medication decisions require a clinician evaluation.
Untreated perimenopause matters long-term. Beyond symptom burden, untreated estrogen deficiency is associated with accelerated bone loss and increased lifetime risk of osteoporosis, and in some populations with increased cardiovascular disease risk, particularly when menopause is early. Timing of HRT initiation and route of delivery influence the risk-benefit picture significantly. We discuss the longer-term postmenopausal picture too, so you can plan beyond the immediate symptoms. For formal psychotherapy, we collaborate with trusted therapy partners across the region.
What about hormone pellets?
Some clinics in the Omaha and Papillion area offer compounded hormone pellets, small implants placed under the skin every three to four months. We do not offer pellets, and here is why:
- FDA approval. Pellet formulations are compounded, not FDA-approved. Transdermal estradiol (patches, gels, sprays) and oral micronized progesterone (Prometrium) are FDA-approved, have decades of safety and efficacy data, and are the first-line recommendation from The Menopause Society (formerly NAMS) and the Endocrine Society.
- Dose control. Pellets deliver supraphysiologic (above-normal) hormone levels in the weeks after insertion, then decline unpredictably. Patches, gels, and oral progesterone allow steady, titrated dosing and let us adjust based on your labs and symptoms.
- Reversibility. If you develop side effects from a pellet, it cannot be removed. A patch or gel can be stopped or dose-adjusted immediately.
- Cost and transparency. Pellets typically run several hundred dollars every three to four months, and pricing is not always clearly disclosed upfront. We use generic FDA-approved medications that are often covered by prescription insurance.
Our approach follows evidence-based prescribing: transdermal estradiol, oral micronized progesterone, and non-hormonal options when clinically appropriate. For testosterone in women, we use low-dose topical formulations rather than pellets. If you are currently on pellets and want to transition to a monitored, reversible regimen, we can help with that.
Pricing
Transparent, self-pay pricing.
Initial Consultation
- Full history, symptom review, and exam.
- Lab order sent to your preferred lab.
- Written individualized treatment plan.
- Prescription sent to your preferred pharmacy.
Follow-Up Visit
- Lab review and dose adjustments.
- Symptom tracking and refinement.
- Refills and ongoing management.
- Patient-portal messaging between visits.
Why self-pay for HRT? Hormone therapy is not billed to insurance at our practice. Self-pay keeps visits longer, keeps the clinician (not a payer) in charge of the plan, and lets us spend the time perimenopause actually deserves. A good-faith estimate is provided on request. Lab costs are separate and billed by your lab; most commercial plans cover routine labs, and many labs offer cash-pay pricing. Prescription costs are billed by your pharmacy and generally work with your prescription insurance if you have it.
Perimenopause care in Papillion, Omaha & 16 states.
We see women in person at our Papillion, Nebraska office, serving patients across the Omaha metro including Bellevue, La Vista, Gretna, Elkhorn, and Council Bluffs, and by secure telehealth in every state where we are licensed. Labs are drawn locally, and prescriptions are sent to your preferred pharmacy.
Licensed for telehealth in these 16 states:
FAQ
Common questions about perimenopause.
Am I in perimenopause?
Perimenopause typically begins between ages 35 and 48, though the range is wide. Early signs include cycle length changes, new sleep disruption, worsening PMS, hot flashes or night sweats, mood volatility, brain fog, and joint aches. You can be in perimenopause with a still-regular cycle. Diagnosis is primarily clinical, based on your age, symptoms, and cycle pattern.
Do I need lab tests?
Labs are not required to diagnose perimenopause, but they are useful. We typically check FSH, estradiol, TSH, DHEA-S, CBC, CMP, lipids, vitamin D, vitamin B12, and ferritin. FSH and estradiol fluctuate wildly in perimenopause, so a single value rarely tells the whole story. Labs help rule out thyroid disease and anemia and establish a baseline before starting hormone therapy.
Is HRT safe?
For most healthy women under 60 or within 10 years of menopause, hormone therapy is considered safe and is endorsed by major professional societies for bothersome symptoms. Risk depends on personal history, type of hormone, route (oral vs transdermal), and dose. Contraindications include estrogen-sensitive cancers (breast, endometrial), active thromboembolic disease, undiagnosed vaginal bleeding, and severe liver disease. We review your history before prescribing.
What about the WHI study?
The 2002 Women's Health Initiative results caused a sharp decline in HRT use. In the years since, the data have been re-analyzed, and most experts now recognize that the original findings applied mainly to older women started on oral conjugated estrogens plus synthetic progestin many years past menopause. For symptomatic women in their 40s and 50s, the risk-benefit profile looks very different. Timing of initiation and route of delivery matter.
Can I get hormone therapy by telehealth?
Yes. We provide perimenopause care by secure video telehealth for patients physically located in any of our 16 licensed states. Labs are drawn at a local lab and prescriptions are sent to your pharmacy. In-person visits are available at our Papillion office.
How long do perimenopause symptoms last?
Perimenopause itself averages 4 to 8 years, but hot flashes and night sweats continue for 7 to 10 years on average. Genitourinary symptoms tend to persist or worsen after menopause unless treated. Treatment duration is individualized; many women stay on therapy through the transition and into early postmenopause.
What's the difference between perimenopause and menopause?
Perimenopause is the hormonal transition, during which cycles become irregular and hormones fluctuate. Menopause is a single point in time, defined as 12 consecutive months without a period. Everything after that is postmenopause. Many symptoms overlap. See our menopause HRT page for postmenopausal care.
Do you see women who've had hysterectomies?
Yes. Women who have had a hysterectomy often experience perimenopause-like symptoms, particularly if the ovaries were removed or ovarian blood supply was affected. Women without a uterus generally do not need progesterone when taking estrogen, which simplifies the regimen. Women with an intact uterus who take estrogen do need a progestogen to protect the endometrium.
You shouldn't have to white-knuckle perimenopause.
Labs-based, individualized perimenopause care from a dual ANCC board-certified nurse practitioner. $225 initial, $125 follow-up. In person in Papillion or secure telehealth in 16 states.
Book an Appointment